Optimal Acuity Corporation

OPTIMAL ACUITY

THROUGH LASER CORNEAL PHOTOVITRIFICATION

Stay Informed on the

Latest Developments from

OPTIMAL ACUITY CORPORATION

2 Header - Logo Circle
doc-dryamd

AGE-RELATED MACULAR DEGENERATION (AMD)

AMD is an eye condition resulting in loss of central vision, usually in both eyes. It causes an increasing loss of ability to read and navigate, with associated quality of life issues.

AMD is the leading cause of blindness in adults over 50 in most economically developed nations. Macular degeneration affects over 3% of the global population.

CLEAR-K® TREATMENT

The Clear-K® Treatment is being studied for the treatment of dry and wet AMD and other ocular diseases and disorders and is not approved for sale in the United States.  CAUTION Investigational device. Limited by Federal (or the United States) law to investigational use. If you would like to receive updates about clinical studies for the  Clear-K® Treatment, please contact us.
ABOUT US

Developing treatments to preserve and improve vision

PRODUCTS

Developing CPV devices to treat ocular diseases and disorders

THE SCIENCE

Learn about the science supporting the use of CPV

RESEARCH

Learn about the ongoing clinical studies